Borderline drug/device case put before CJEU raises questions over legal interpretation
This article was originally published in Clinica
Executive Summary
A recent case brought before the Court of Justice of the European Union involving a product on the borderline between medical device and medicinal product regulation has raised a number of issues that need addressing to ensure appropriate, informed and consistent legal judgments are made in cases involving complex technology healthcare products.